Aug 7 (Reuters) - Firebrick Pharma Ltd (FRE) :
- FIREBRICK COVID-19 TRIAL ACHIEVES PRIMARY ENDPOINT
- PHASE 2 TRIAL OF NASODINE NASAL SPRAY IN COVID-19 ACHIEVED ITS PRIMARY ENDPOINT
News: FRE Firebrick Pharma Says Firebrick COVID-19 Trial Achieves Primary Endpoint
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add FRE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.93M | |||
| Open | High | Low | Value | Volume |
| 6.0¢ | 6.4¢ | 5.6¢ | $10.79K | 175.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 123214 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.5¢ | 64010 | 2 |
View Market Depth
| Last trade - 15.53pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
6.5¢ |
Change
0.000 ( 6.56 %) |
||||
| Open | High | Low | Volume | ||
| 6.5¢ | 6.5¢ | 6.5¢ | 2828 | ||
| Last updated 12.40pm 07/06/2024 ? | |||||
| FRE (ASX) Chart |